COVID-19 upended the health insurance sector, but the impact on enrollment in Individual & Family Plans (IFP) was particularly strong. When the economy slowed, millions of Americans lost their jobs and their employer-based insurance. Many turned to the individual insurance markets to find coverage. Carrot Health analyzed Open Enrollment Period (OEP) data from the National Association of Insurance Commissioners (NAIC) and the Centers for Medicare & Medicaid Services (CMS) to understand the impact on IFP enrollment in 2021.
The healthcare industry is evolving to place people at the heart of operations. Organizations are broadening — and connecting disparate — data sources to understand individuals holistically, resulting in innovative strategies. Pharmaceutical companies, known to put patients first, are critical in this people-centric approach. Are you ready to dive deeper to tailor your patients’ experience using the power of data?
Pharmaceutical companies leveraging limited sets of clinical and prescription data are experiencing limited results, and missing critical opportunities. By failing to use real-time, data-informed strategy, they’re likely seeing lower engagement, adherence, and ultimately, less revenue over time.
Minority communities are not all equal. In fact, they’re incredibly diverse—particularly when looking at population mix and rural vs. urban areas. These communities can have different household makeups, risk factors, and varying engagement preferences—all impacting health outcomes.
By understanding populations at a local level, you can help improve health outcomes, member engagement, costs, and public health.
In 2020, we experienced an unprecedented year with a global pandemic with social and economic impacts, rising racial inequalities, and strong political division leading to a contentious presidential election. Many predicted this would lead to a distinctly different Annual Election Period (AEP) for Medicare plans with a high degree of consumer uncertainty. In this report, we discuss our post-AEP observations and highlight health plan trends, results, and key findings.
Vaccines, considered one of the most important advances in modern medicine, have greatly improved our quality of life by reducing or eliminating many infectious diseases. Worldwide, immunization can prevent up to 3 million deaths per year. Vaccines are “one of the most successful and cost-effective public health interventions,” according to the World Health Organization.
As we navigate the next phase in the COVID-19 pandemic, with multiple promising vaccine options in sight, there is much debate on who should be first in line to get vaccinated.